| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 5.96e-06 | 14 | 180 | 4 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 4.95e-05 | 23 | 180 | 4 | GO:0034235 | |
| GeneOntologyMolecularFunction | actin binding | MYH3 PSG1 MAP2 PSG3 PSG9 SYNE1 SPTA1 LRRK2 SHROOM4 ANLN SYNE2 MACF1 PSG8 DIAPH3 | 1.18e-04 | 479 | 180 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | filamin binding | 1.27e-04 | 29 | 180 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.27e-04 | 29 | 180 | 4 | GO:0035325 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 2.40e-04 | 34 | 180 | 4 | GO:0015125 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 4.24e-04 | 70 | 180 | 5 | GO:1901618 | |
| GeneOntologyMolecularFunction | kinase binding | PSG1 MAP2 PSG3 PSG7 PSG9 NAIP PER1 PPEF2 IFNAR2 PTPRK PRDX3 PARN PSG8 RAPGEF2 CDC42 EP300 TOP2A PRLR WWC1 VDAC1 | 4.82e-04 | 969 | 180 | 20 | GO:0019900 |
| GeneOntologyMolecularFunction | NAADP-sensitive calcium-release channel activity | 7.94e-04 | 5 | 180 | 2 | GO:0072345 | |
| GeneOntologyMolecularFunction | alkylglycerophosphoethanolamine phosphodiesterase activity | 7.94e-04 | 5 | 180 | 2 | GO:0047391 | |
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 7.94e-04 | 5 | 180 | 2 | GO:0052871 | |
| GeneOntologyMolecularFunction | fibroblast growth factor receptor activity | 7.94e-04 | 5 | 180 | 2 | GO:0005007 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 7.94e-04 | 5 | 180 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | protein kinase binding | PSG1 MAP2 PSG3 PSG7 PSG9 NAIP PPEF2 IFNAR2 PTPRK PRDX3 PARN PSG8 RAPGEF2 CDC42 EP300 TOP2A PRLR VDAC1 | 9.42e-04 | 873 | 180 | 18 | GO:0019901 |
| GeneOntologyMolecularFunction | glycolipid binding | 9.86e-04 | 49 | 180 | 4 | GO:0051861 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 9.99e-04 | 173 | 180 | 7 | GO:0070851 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.23e-03 | 52 | 180 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.33e-03 | 90 | 180 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH3 HBS1L RRAS2 DDX60 ENPP3 LRRK2 NAIP RRAS SHOC1 MACF1 GNA11 GNAQ ASCC3 POLQ CDC42 DNAH11 TDRD12 | 1.57e-03 | 839 | 180 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH3 HBS1L RRAS2 DDX60 ENPP3 LRRK2 NAIP RRAS SHOC1 MACF1 GNA11 GNAQ ASCC3 POLQ CDC42 DNAH11 TDRD12 | 1.59e-03 | 840 | 180 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH3 HBS1L RRAS2 DDX60 ENPP3 LRRK2 NAIP RRAS SHOC1 MACF1 GNA11 GNAQ ASCC3 POLQ CDC42 DNAH11 TDRD12 | 1.59e-03 | 840 | 180 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 1.65e-03 | 7 | 180 | 2 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 1.65e-03 | 7 | 180 | 2 | GO:0018685 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.71e-03 | 140 | 180 | 6 | GO:0099094 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH3 HBS1L RRAS2 DDX60 LRRK2 NAIP RRAS SHOC1 MACF1 GNA11 GNAQ ASCC3 POLQ CDC42 DNAH11 TDRD12 | 1.79e-03 | 775 | 180 | 16 | GO:0017111 |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 5.30e-08 | 24 | 183 | 6 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 1.80e-07 | 29 | 183 | 6 | GO:2001212 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.54e-06 | 23 | 183 | 5 | GO:0002858 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 1.93e-06 | 24 | 183 | 5 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 1.93e-06 | 24 | 183 | 5 | GO:0002420 | |
| GeneOntologyBiologicalProcess | head development | MYH3 AARS1 RPGRIP1L SLC6A17 LRRK2 RRAS TFAP2A SEMA3A SHROOM4 KIRREL3 SETD2 C2CD3 BRCA2 SYNE2 UBA6 FGFR1 FGFR3 GNAQ DIAPH3 RAPGEF2 CPLANE1 CDC42 HYDIN EP300 | 2.17e-06 | 919 | 183 | 24 | GO:0060322 |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 2.39e-06 | 25 | 183 | 5 | GO:0002423 | |
| GeneOntologyBiologicalProcess | MAPK cascade | SETX CHRNA9 ERN1 PSG1 PSG3 PSG9 DUSP4 LRRK2 NAIP PER1 RRAS PPEF2 CD84 SEMA3A CCL3 FGF12 PSG8 FGFR1 FGFR3 STK40 RAPGEF2 CDC42 NOTCH2 WWC1 | 2.66e-06 | 930 | 183 | 24 | GO:0000165 |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | CHRNA9 ERN1 PSG1 PSG3 PSG9 DUSP4 LRRK2 NAIP PER1 RRAS PPEF2 CD84 SEMA3A CCL3 PSG8 FGFR1 FGFR3 STK40 RAPGEF2 CDC42 NOTCH2 WWC1 | 3.52e-06 | 815 | 183 | 22 | GO:0043408 |
| GeneOntologyBiologicalProcess | epithelium development | RAPGEF6 RPGRIP1L GCM2 PSG1 PSG3 PSG9 CLIC4 TFAP2A TFAP2B TRIM16 SEMA3A SETDB2 SETD2 FAT1 C2CD3 BRCA2 SCNN1G PSG8 FGFR1 FGFR3 ASB2 RAPGEF2 CSMD1 CPLANE1 CDC42 USH2A HYDIN EP300 PRLR MCOLN3 NOTCH2 | 5.56e-06 | 1469 | 183 | 31 | GO:0060429 |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 5.60e-06 | 14 | 183 | 4 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 7.58e-06 | 15 | 183 | 4 | GO:0070347 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 7.58e-06 | 15 | 183 | 4 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 7.58e-06 | 15 | 183 | 4 | GO:0002859 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 7.58e-06 | 15 | 183 | 4 | GO:1903387 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 9.25e-06 | 116 | 183 | 8 | GO:0045670 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 1.00e-05 | 16 | 183 | 4 | GO:0038016 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 1.05e-05 | 118 | 183 | 8 | GO:0001570 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.30e-05 | 17 | 183 | 4 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.30e-05 | 17 | 183 | 4 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.30e-05 | 17 | 183 | 4 | GO:0038158 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 1.36e-05 | 35 | 183 | 5 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 1.66e-05 | 18 | 183 | 4 | GO:1903385 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 1.92e-05 | 93 | 183 | 7 | GO:1901184 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 2.60e-05 | 20 | 183 | 4 | GO:2000346 | |
| GeneOntologyBiologicalProcess | metal ion transport | KLHL24 SLC11A2 CHRNA9 HECW1 SLC6A17 PER1 SLC6A15 MCOLN1 CD84 GRAMD2A MELTF KCNU1 KCNQ5 CLIC2 SCN4A KCNJ16 SCNN1G CCL3 FGF12 GNAQ SLC5A12 MCOLN3 VDAC1 | 2.78e-05 | 1000 | 183 | 23 | GO:0030001 |
| GeneOntologyBiologicalProcess | gland morphogenesis | 3.11e-05 | 178 | 183 | 9 | GO:0022612 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 3.19e-05 | 21 | 183 | 4 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 3.19e-05 | 21 | 183 | 4 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 3.19e-05 | 21 | 183 | 4 | GO:0002838 | |
| GeneOntologyBiologicalProcess | sodium ion transport | KLHL24 HECW1 SLC6A17 PER1 SLC6A15 MCOLN1 SCN4A SCNN1G FGF12 SLC5A12 MCOLN3 | 3.64e-05 | 275 | 183 | 11 | GO:0006814 |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 3.87e-05 | 22 | 183 | 4 | GO:0030853 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 3.99e-05 | 71 | 183 | 6 | GO:0002347 | |
| GeneOntologyBiologicalProcess | cell projection assembly | RAPGEF6 RPGRIP1L DNAAF4 SYNE1 FSIP2 C2CD3 CFAP54 ANLN RAB3IP SYNE2 DNAAF6 FGFR1 RP1 RAPGEF2 CPLANE1 CDC42 HYDIN CDH13 | 4.08e-05 | 685 | 183 | 18 | GO:0030031 |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 4.21e-05 | 185 | 183 | 9 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 4.21e-05 | 185 | 183 | 9 | GO:0035108 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 4.58e-05 | 187 | 183 | 9 | GO:0007156 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 4.65e-05 | 23 | 183 | 4 | GO:0090331 | |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | ERN1 PSG1 PSG3 PSG9 LRRK2 NAIP CD84 SEMA3A CCL3 PSG8 FGFR1 FGFR3 RAPGEF2 CDC42 NOTCH2 WWC1 | 5.24e-05 | 571 | 183 | 16 | GO:0043410 |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 5.31e-05 | 46 | 183 | 5 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 5.31e-05 | 46 | 183 | 5 | GO:0072574 | |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 5.39e-05 | 148 | 183 | 8 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 5.39e-05 | 148 | 183 | 8 | GO:0035113 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 5.87e-05 | 76 | 183 | 6 | GO:0042269 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 6.56e-05 | 25 | 183 | 4 | GO:0035726 | |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 6.66e-05 | 294 | 183 | 11 | GO:0044706 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 7.23e-05 | 49 | 183 | 5 | GO:0002837 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 7.23e-05 | 49 | 183 | 5 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 7.84e-05 | 80 | 183 | 6 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 7.84e-05 | 80 | 183 | 6 | GO:0046850 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 7.98e-05 | 50 | 183 | 5 | GO:0002834 | |
| GeneOntologyBiologicalProcess | female pregnancy | 8.00e-05 | 249 | 183 | 10 | GO:0007565 | |
| GeneOntologyBiologicalProcess | brain development | AARS1 RPGRIP1L SLC6A17 LRRK2 TFAP2A SEMA3A SHROOM4 KIRREL3 SETD2 C2CD3 BRCA2 SYNE2 UBA6 FGFR1 FGFR3 GNAQ RAPGEF2 CPLANE1 CDC42 HYDIN | 8.12e-05 | 859 | 183 | 20 | GO:0007420 |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 8.97e-05 | 27 | 183 | 4 | GO:0070344 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | KLHL24 SLC11A2 CHRNA9 HECW1 SLC6A17 PER1 SLC6A15 MCOLN1 CD84 GRAMD2A MELTF KCNU1 KCNQ5 CLIC2 SCN4A KCNJ16 SCNN1G CCL3 FGF12 GNAQ SLC5A12 UQCRFS1 MCOLN3 VDAC1 | 9.37e-05 | 1157 | 183 | 24 | GO:0006812 |
| GeneOntologyBiologicalProcess | osteoclast differentiation | 1.02e-04 | 162 | 183 | 8 | GO:0030316 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | RAPGEF6 RPGRIP1L DNAAF4 SYNE1 FSIP2 C2CD3 CFAP54 ANLN RAB3IP SYNE2 DNAAF6 RP1 RAPGEF2 CPLANE1 CDC42 HYDIN CDH13 | 1.03e-04 | 670 | 183 | 17 | GO:0120031 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | KLHL24 HECW1 SLC6A17 SLC6A15 MCOLN1 SCN4A SCNN1G FGF12 MCOLN3 | 1.04e-04 | 208 | 183 | 9 | GO:0035725 |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 1.04e-04 | 28 | 183 | 4 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 1.17e-04 | 86 | 183 | 6 | GO:0042058 | |
| GeneOntologyBiologicalProcess | behavior | SLC11A2 PSG1 PSG3 DNAAF4 PSG9 LRRK2 ALS2 KIRREL3 DMRT3 UBA6 CCL3 FGF12 PSG8 ALB GNAQ CSMD1 EP300 MCOLN3 VDAC1 DNAH11 | 1.33e-04 | 891 | 183 | 20 | GO:0007610 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | RPGRIP1L CLIC4 TFAP2A SEMA3A SETDB2 SETD2 FAT1 C2CD3 SCNN1G FGFR1 FGFR3 ASB2 CSMD1 CPLANE1 CDC42 NOTCH2 | 1.34e-04 | 619 | 183 | 16 | GO:0002009 |
| GeneOntologyBiologicalProcess | forebrain neuron development | 1.37e-04 | 30 | 183 | 4 | GO:0021884 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 1.38e-04 | 56 | 183 | 5 | GO:0002418 | |
| GeneOntologyBiologicalProcess | bone remodeling | 1.41e-04 | 127 | 183 | 7 | GO:0046849 | |
| GeneOntologyBiologicalProcess | gland development | CAD RPGRIP1L GCM2 PSG1 PSG3 PSG9 SEMA3A IGF2R BRCA2 PSG8 FGFR1 CSMD1 CDC42 PRLR NOTCH2 | 1.42e-04 | 558 | 183 | 15 | GO:0048732 |
| GeneOntologyBiologicalProcess | heart development | CAD RPGRIP1L DNAAF4 SYNE1 TFAP2A SETDB2 SETD2 C2CD3 GNA11 FGF12 FGFR1 GNAQ ASB2 CPLANE1 CDC42 EP300 NOTCH2 DNAH11 | 1.45e-04 | 757 | 183 | 18 | GO:0007507 |
| GeneOntologyBiologicalProcess | regulation of tissue remodeling | 1.48e-04 | 128 | 183 | 7 | GO:0034103 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | RPGRIP1L CHRNA9 PSG1 PSG3 PSG9 LRRK2 TFAP2A SEMA3A SETDB2 SETD2 FAT1 C2CD3 DMRT3 PSG8 FGFR1 RP1 FGFR3 STK40 ASB2 CSMD1 CDC42 USH2A EP300 NOTCH2 DNAH11 | 1.49e-04 | 1269 | 183 | 25 | GO:0009887 |
| GeneOntologyBiologicalProcess | positive regulation of MAP kinase activity | 1.55e-04 | 129 | 183 | 7 | GO:0043406 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.56e-04 | 31 | 183 | 4 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 1.77e-04 | 59 | 183 | 5 | GO:0045671 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 1.78e-04 | 32 | 183 | 4 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 1.78e-04 | 32 | 183 | 4 | GO:0045779 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 1.78e-04 | 32 | 183 | 4 | GO:0060312 | |
| GeneOntologyBiologicalProcess | limb development | 1.82e-04 | 224 | 183 | 9 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 1.82e-04 | 224 | 183 | 9 | GO:0048736 | |
| GeneOntologyBiologicalProcess | circulatory system development | CAD RPGRIP1L PSG1 PSG3 DNAAF4 PSG9 SYNE1 CLIC4 RRAS TFAP2A TFAP2B SETDB2 SETD2 C2CD3 GNA11 FGF12 PSG8 FGFR1 GNAQ ASB2 RAPGEF2 CPLANE1 CDC42 EP300 CDH13 NOTCH2 DNAH11 | 1.82e-04 | 1442 | 183 | 27 | GO:0072359 |
| GeneOntologyBiologicalProcess | endothelin receptor signaling pathway | 1.84e-04 | 13 | 183 | 3 | GO:0086100 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 2.01e-04 | 33 | 183 | 4 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 2.01e-04 | 33 | 183 | 4 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 2.26e-04 | 34 | 183 | 4 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 2.26e-04 | 34 | 183 | 4 | GO:0046851 | |
| GeneOntologyBiologicalProcess | regulation of myeloid leukocyte differentiation | 2.27e-04 | 182 | 183 | 8 | GO:0002761 | |
| GeneOntologyBiologicalProcess | multi-organism reproductive process | 2.76e-04 | 290 | 183 | 10 | GO:0044703 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | RAPGEF6 GCM2 PSG1 PSG3 PSG9 CLIC4 TFAP2A TRIM16 FAT1 PSG8 FGFR1 FGFR3 RAPGEF2 CDC42 USH2A HYDIN PRLR MCOLN3 NOTCH2 | 2.78e-04 | 870 | 183 | 19 | GO:0030855 |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | ERN1 PSG1 PSG3 PSG9 LRRK2 ALS2 PSG8 FGFR1 FGFR3 RAPGEF2 PRLR NOTCH2 | 2.79e-04 | 405 | 183 | 12 | GO:0033674 |
| GeneOntologyBiologicalProcess | forebrain generation of neurons | 2.79e-04 | 65 | 183 | 5 | GO:0021872 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 3.00e-04 | 66 | 183 | 5 | GO:0010543 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | ERN1 PSG1 PSG3 PSG9 LRRK2 ALS2 PSG8 FGFR1 RAPGEF2 PRLR NOTCH2 | 3.05e-04 | 350 | 183 | 11 | GO:0045860 |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | 3.37e-04 | 193 | 183 | 8 | GO:0071902 | |
| GeneOntologyBiologicalProcess | cilium organization | RPGRIP1L DNAAF4 SYNE1 FSIP2 C2CD3 CFAP54 RAB3IP SYNE2 NECTIN2 DNAAF6 RP1 CPLANE1 HYDIN | 3.42e-04 | 476 | 183 | 13 | GO:0044782 |
| GeneOntologyBiologicalProcess | regulation of cell killing | 3.46e-04 | 147 | 183 | 7 | GO:0031341 | |
| GeneOntologyBiologicalProcess | regulation of MAP kinase activity | 3.49e-04 | 194 | 183 | 8 | GO:0043405 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 3.50e-04 | 105 | 183 | 6 | GO:0042267 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 3.50e-04 | 38 | 183 | 4 | GO:2000345 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | RPGRIP1L CLIC4 TFAP2A SEMA3A SETDB2 SETD2 FAT1 C2CD3 SCNN1G MACF1 FGFR1 FGFR3 ASB2 CSMD1 CPLANE1 CDC42 NOTCH2 | 3.86e-04 | 750 | 183 | 17 | GO:0048729 |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 3.87e-04 | 39 | 183 | 4 | GO:0045717 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 3.95e-04 | 70 | 183 | 5 | GO:0045124 | |
| GeneOntologyBiologicalProcess | regulation of cell activation | PAG1 PSG1 PSG3 PSG9 ENPP3 SPTA1 LRRK2 CD55 CD84 RIF1 NECTIN2 CCL3 PSG8 FGFR1 GNAQ EP300 PRLR | 4.23e-04 | 756 | 183 | 17 | GO:0050865 |
| GeneOntologyCellularComponent | apical part of cell | CYP4F8 RAPGEF6 SLC11A2 PSG1 PSG3 PSG9 ENPP3 CD55 CLIC4 SHROOM4 FAT1 SCNN1G PSG8 SLC5A12 RAPGEF2 CDC42 USH2A CYP4F11 | 5.24e-06 | 592 | 184 | 18 | GO:0045177 |
| GeneOntologyCellularComponent | apical plasma membrane | CYP4F8 RAPGEF6 SLC11A2 PSG1 PSG3 PSG9 ENPP3 CD55 SHROOM4 FAT1 SCNN1G PSG8 SLC5A12 RAPGEF2 USH2A CYP4F11 | 6.86e-06 | 487 | 184 | 16 | GO:0016324 |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 9.73e-06 | 16 | 184 | 4 | GO:0070021 | |
| GeneOntologyCellularComponent | cilium | CATSPERE RPGRIP1L PSG1 PSG3 DNAAF4 PSG9 PPEF2 FSIP2 C2CD3 CFAP54 ARR3 KCNU1 PTPRK GNA11 PSG8 RP1 GNAQ CPLANE1 USH2A HYDIN NOTCH2 DNAH11 | 1.44e-05 | 898 | 184 | 22 | GO:0005929 |
| GeneOntologyCellularComponent | anchoring junction | RRAS2 KLHL24 RPGRIP1L PSG1 PSG3 PSG9 CLIC4 RRAS PIKFYVE SHROOM4 KIRREL3 FAT1 IGF2R PTPRK ARHGAP31 SYNE2 NECTIN2 PSG8 FGFR3 FLRT1 RAPGEF2 CDC42 CDH13 | 1.68e-05 | 976 | 184 | 23 | GO:0070161 |
| GeneOntologyCellularComponent | cell-cell junction | KLHL24 RPGRIP1L PSG1 PSG3 PSG9 CLIC4 PIKFYVE SHROOM4 KIRREL3 FAT1 PTPRK NECTIN2 PSG8 FLRT1 RAPGEF2 CDC42 CDH13 | 1.98e-05 | 591 | 184 | 17 | GO:0005911 |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 3.26e-05 | 139 | 184 | 8 | GO:0097733 | |
| GeneOntologyCellularComponent | membrane protein complex | TRAV7 CATSPERE CHRNA9 ERN1 PSG1 PSG3 PSG9 SYNE1 TMED7 CLIC4 SEC31A IL18RAP IGF2R KCNU1 KCNQ5 CLIC2 SYNE2 SCN4A KCNJ16 SCNN1G GNA11 PSG8 GNAQ DIAPH3 UQCRFS1 IMMT CDH13 VDAC1 TRAV14DV4 | 4.95e-05 | 1498 | 184 | 29 | GO:0098796 |
| GeneOntologyCellularComponent | non-motile cilium | 6.21e-05 | 196 | 184 | 9 | GO:0097730 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 6.46e-05 | 153 | 184 | 8 | GO:0097731 | |
| GeneOntologyCellularComponent | adherens junction | 1.13e-04 | 212 | 184 | 9 | GO:0005912 | |
| GeneOntologyCellularComponent | cell surface | SPAM1 SLC11A2 PSG1 PSG3 PSG7 PSG9 ENPP3 CD55 CLIC4 ADAM28 CD84 MELTF IGF2R PTPRK NECTIN2 CUZD1 SCNN1G PSG8 FGFR3 PRLR CDH13 NOTCH2 | 3.21e-04 | 1111 | 184 | 22 | GO:0009986 |
| GeneOntologyCellularComponent | photoreceptor outer segment | 4.52e-04 | 111 | 184 | 6 | GO:0001750 | |
| GeneOntologyCellularComponent | focal adhesion | RRAS2 RRAS SHROOM4 FAT1 IGF2R ARHGAP31 SYNE2 NECTIN2 FGFR3 FLRT1 CDC42 CDH13 | 4.55e-04 | 431 | 184 | 12 | GO:0005925 |
| GeneOntologyCellularComponent | cell-substrate junction | RRAS2 RRAS SHROOM4 FAT1 IGF2R ARHGAP31 SYNE2 NECTIN2 FGFR3 FLRT1 CDC42 CDH13 | 5.80e-04 | 443 | 184 | 12 | GO:0030055 |
| GeneOntologyCellularComponent | side of membrane | SPAM1 PSG1 PSG3 PSG9 ENPP3 SPTA1 LRRK2 CD55 CD84 SHROOM4 MELTF SCNN1G GNA11 PSG8 FGFR3 GNAQ PRLR CDH13 | 7.43e-04 | 875 | 184 | 18 | GO:0098552 |
| GeneOntologyCellularComponent | Mon1-Ccz1 complex | 7.57e-04 | 5 | 184 | 2 | GO:0035658 | |
| GeneOntologyCellularComponent | DNA repair complex | 1.04e-03 | 23 | 184 | 3 | GO:1990391 | |
| GeneOntologyCellularComponent | receptor complex | TRAV7 CHRNA9 PSG1 PSG3 PSG9 IL18RAP MCOLN1 PSG8 FGFR1 FGFR3 PRLR NOTCH2 TRAV14DV4 | 1.97e-03 | 581 | 184 | 13 | GO:0043235 |
| GeneOntologyCellularComponent | stereocilia coupling link | 2.08e-03 | 8 | 184 | 2 | GO:0002139 | |
| MousePheno | decreased fatty acid oxidation | 6.78e-06 | 24 | 161 | 5 | MP:0014172 | |
| MousePheno | decreased carbon dioxide production | 2.54e-05 | 31 | 161 | 5 | MP:0008964 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 3.59e-05 | 17 | 161 | 4 | MP:0031047 | |
| Domain | Ig_2 | 6.55e-06 | 73 | 180 | 7 | PF13895 | |
| Domain | ig | 1.60e-05 | 190 | 180 | 10 | PF00047 | |
| Domain | Immunoglobulin | 1.60e-05 | 190 | 180 | 10 | IPR013151 | |
| Domain | Spectrin | 6.40e-05 | 23 | 180 | 4 | PF00435 | |
| Domain | DUF1712 | 9.24e-05 | 2 | 180 | 2 | PF08217 | |
| Domain | DUF1712_fun | 9.24e-05 | 2 | 180 | 2 | IPR013176 | |
| Domain | Spectrin_repeat | 1.64e-04 | 29 | 180 | 4 | IPR002017 | |
| Domain | IG | PSG1 PSG3 PSG7 PSG9 IL18RAP CD84 SEMA3A KIRREL3 PTPRK NECTIN2 PSG8 FGFR1 FGFR3 | 2.30e-04 | 421 | 180 | 13 | SM00409 |
| Domain | Ig_sub | PSG1 PSG3 PSG7 PSG9 IL18RAP CD84 SEMA3A KIRREL3 PTPRK NECTIN2 PSG8 FGFR1 FGFR3 | 2.30e-04 | 421 | 180 | 13 | IPR003599 |
| Domain | - | PSG1 PSG3 PSG7 PSG9 IL18RAP IFNAR2 CD84 SEMA3A KIRREL3 PTPRK NECTIN2 PSG8 FGFR1 FGFR3 FLRT1 USH2A PRLR | 2.39e-04 | 663 | 180 | 17 | 2.60.40.10 |
| Domain | SPEC | 2.43e-04 | 32 | 180 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.43e-04 | 32 | 180 | 4 | IPR018159 | |
| Domain | - | 2.75e-04 | 3 | 180 | 2 | 2.102.10.10 | |
| Domain | RIESKE | 2.75e-04 | 3 | 180 | 2 | PS51296 | |
| Domain | Rieske | 2.75e-04 | 3 | 180 | 2 | PF00355 | |
| Domain | Rieske_2Fe-2S | 2.75e-04 | 3 | 180 | 2 | IPR017941 | |
| Domain | Ig-like_fold | PSG1 PSG3 PSG7 PSG9 IL18RAP IFNAR2 CD84 SEMA3A KIRREL3 PTPRK NECTIN2 PSG8 FGFR1 FGFR3 FLRT1 USH2A PRLR | 4.92e-04 | 706 | 180 | 17 | IPR013783 |
| Domain | KASH | 5.47e-04 | 4 | 180 | 2 | IPR012315 | |
| Domain | KASH | 5.47e-04 | 4 | 180 | 2 | PS51049 | |
| Domain | KASH | 5.47e-04 | 4 | 180 | 2 | SM01249 | |
| Domain | KASH | 5.47e-04 | 4 | 180 | 2 | PF10541 | |
| Domain | Gprotein_alpha_Q | 5.47e-04 | 4 | 180 | 2 | IPR000654 | |
| Domain | FGF_rcpt_fam | 5.47e-04 | 4 | 180 | 2 | IPR016248 | |
| Domain | RCC1 | 8.89e-04 | 20 | 180 | 3 | PF00415 | |
| Domain | TF_AP2 | 9.06e-04 | 5 | 180 | 2 | IPR004979 | |
| Domain | TF_AP2_C | 9.06e-04 | 5 | 180 | 2 | IPR013854 | |
| Domain | TF_AP-2 | 9.06e-04 | 5 | 180 | 2 | PF03299 | |
| Domain | Na/ntran_symport_orphan | 9.06e-04 | 5 | 180 | 2 | IPR002438 | |
| Domain | IG_LIKE | PSG1 PSG3 PSG7 PSG9 IL18RAP CD84 SEMA3A KIRREL3 PTPRK NECTIN2 PSG8 FGFR1 FGFR3 | 9.77e-04 | 491 | 180 | 13 | PS50835 |
| Domain | RCC1_1 | 1.03e-03 | 21 | 180 | 3 | PS00625 | |
| Domain | RCC1_2 | 1.03e-03 | 21 | 180 | 3 | PS00626 | |
| Domain | RCC1_3 | 1.03e-03 | 21 | 180 | 3 | PS50012 | |
| Domain | - | 1.18e-03 | 22 | 180 | 3 | 2.130.10.30 | |
| Domain | Reg_chr_condens | 1.18e-03 | 22 | 180 | 3 | IPR000408 | |
| Domain | Ig-like_dom | PSG1 PSG3 PSG7 PSG9 IL18RAP CD84 SEMA3A KIRREL3 PTPRK NECTIN2 PSG8 FGFR1 FGFR3 | 1.21e-03 | 503 | 180 | 13 | IPR007110 |
| Domain | CLIC | 1.35e-03 | 6 | 180 | 2 | IPR002946 | |
| Domain | ACTININ_2 | 1.35e-03 | 23 | 180 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.35e-03 | 23 | 180 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.35e-03 | 23 | 180 | 3 | IPR001589 | |
| Domain | RCC1/BLIP-II | 1.35e-03 | 23 | 180 | 3 | IPR009091 | |
| Pubmed | 7.56e-09 | 14 | 184 | 5 | 14517298 | ||
| Pubmed | CCZ1B HBS1L RAPGEF6 SETX ERCC5 CD55 TMED7 ALS2 SEC31A ME2 WDFY4 DIS3 ESF1 GRAMD2A IGF2R CCZ1 PTCD1 ANLN MACF1 GNA11 CPLANE1 CDC42 HERC4 | 1.74e-08 | 1084 | 184 | 23 | 11544199 | |
| Pubmed | KBTBD3 CAD SYNE1 SLC6A17 TMED7 SEC31A RNF17 TRIM16 SETDB2 SETD2 BRCA2 PRDX3 SYNE2 ALB IMMT EP300 WWC1 VDAC1 | 1.24e-07 | 754 | 184 | 18 | 35906200 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 2341148 | ||
| Pubmed | In vivo validation of late-onset Alzheimer's disease genetic risk factors. | 1.91e-07 | 25 | 184 | 5 | 38687251 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 5.22e-07 | 13 | 184 | 4 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 5.22e-07 | 13 | 184 | 4 | 19273835 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 20044046 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 32150576 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 6265583 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 5.22e-07 | 13 | 184 | 4 | 12832451 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 25406283 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 8380065 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 1279194 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 25724769 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 5.22e-07 | 13 | 184 | 4 | 22092845 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 5.22e-07 | 13 | 184 | 4 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 5.22e-07 | 13 | 184 | 4 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 5.22e-07 | 13 | 184 | 4 | 23800882 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 19285068 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 5.22e-07 | 13 | 184 | 4 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 5.22e-07 | 13 | 184 | 4 | 39168268 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 8402684 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 5.22e-07 | 13 | 184 | 4 | 21949477 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 26219866 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 2133556 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 19621080 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 5.22e-07 | 13 | 184 | 4 | 19358828 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 16680193 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 5.22e-07 | 13 | 184 | 4 | 34058224 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 10964771 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 5.22e-07 | 13 | 184 | 4 | 23935487 | |
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 5.22e-07 | 13 | 184 | 4 | 25972571 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 5.22e-07 | 13 | 184 | 4 | 15220458 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 18843289 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 15207636 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 21081647 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 11133662 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 11483763 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 18003729 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 20739537 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 5.22e-07 | 13 | 184 | 4 | 27695943 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 20404914 | ||
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 5.22e-07 | 13 | 184 | 4 | 16638824 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 34440862 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 5.22e-07 | 13 | 184 | 4 | 21670291 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 22162753 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 2702644 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 11801635 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 21760897 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 1719235 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 16619040 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 5.22e-07 | 13 | 184 | 4 | 8209741 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 32521208 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 19406938 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 5.22e-07 | 13 | 184 | 4 | 29967450 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 1653760 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 32169849 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 5.22e-07 | 13 | 184 | 4 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 5.22e-07 | 13 | 184 | 4 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 5.22e-07 | 13 | 184 | 4 | 15316023 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 15331748 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 5.22e-07 | 13 | 184 | 4 | 22406619 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 7628460 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 19008452 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 2164599 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 29396368 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 5.22e-07 | 13 | 184 | 4 | 33352461 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 38381498 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 1633107 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 5.22e-07 | 13 | 184 | 4 | 32027621 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 5.22e-07 | 13 | 184 | 4 | 27777319 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 18848945 | ||
| Pubmed | 5.80e-07 | 4 | 184 | 3 | 1572651 | ||
| Pubmed | 7.28e-07 | 14 | 184 | 4 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 7.28e-07 | 14 | 184 | 4 | 34666041 | |
| Pubmed | 7.28e-07 | 14 | 184 | 4 | 34619794 | ||
| Pubmed | 7.28e-07 | 14 | 184 | 4 | 8896983 | ||
| Pubmed | 7.28e-07 | 14 | 184 | 4 | 22962327 | ||
| Pubmed | 7.28e-07 | 14 | 184 | 4 | 17623671 | ||
| Pubmed | 7.28e-07 | 14 | 184 | 4 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 7.28e-07 | 14 | 184 | 4 | 18794798 | |
| Pubmed | 7.28e-07 | 14 | 184 | 4 | 23469261 | ||
| Pubmed | 7.28e-07 | 14 | 184 | 4 | 18454175 | ||
| Pubmed | 7.28e-07 | 14 | 184 | 4 | 29907459 | ||
| Pubmed | 7.28e-07 | 14 | 184 | 4 | 36719377 | ||
| Pubmed | 7.28e-07 | 14 | 184 | 4 | 28567513 | ||
| Pubmed | 7.28e-07 | 14 | 184 | 4 | 8207827 | ||
| Pubmed | 7.28e-07 | 14 | 184 | 4 | 19700760 | ||
| Pubmed | 7.28e-07 | 14 | 184 | 4 | 9212243 | ||
| Interaction | OPHN1 interactions | 1.88e-06 | 24 | 178 | 5 | int:OPHN1 | |
| Cytoband | 19q13.2 | 5.57e-05 | 164 | 184 | 6 | 19q13.2 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 7.64e-09 | 11 | 129 | 5 | 1315 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 3.00e-04 | 4 | 129 | 2 | 1252 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | PSG1 ENPP3 CD55 IL18RAP CD84 MELTF IGF2R NECTIN2 FGFR1 FGFR3 | 5.31e-04 | 394 | 129 | 10 | 471 |
| GeneFamily | Chloride intracellular channels | 7.44e-04 | 6 | 129 | 2 | 307 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.13e-03 | 36 | 129 | 3 | 823 | |
| GeneFamily | Immunoglobulin like domain containing | 2.63e-03 | 193 | 129 | 6 | 594 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RRAS2 SETX SLC11A2 KLF6 AUH DUSP4 ME2 PIKFYVE RIF1 SETD2 FAT1 C2CD3 IGF2R BRCA2 PTPRK SYNE2 MACF1 PARN GNAQ ASCC3 RAPGEF2 HERC4 TOP2A WWC1 | 6.87e-09 | 856 | 182 | 24 | M4500 |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_DN | HBS1L CAD SLC11A2 LRRK2 SEC31A RRAS TFAP2A PAFAH2 MED25 UQCRFS1 TOP2A NOTCH2 | 1.62e-08 | 199 | 182 | 12 | M3843 |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | RRAS2 KLHL24 KLF6 DUSP4 CLIC4 PARP14 ERICH5 IFIT3 ADAM28 CD84 MELTF FAT1 IGF2R PTPRK SYNE2 NECTIN2 PAFAH2 KCNJ16 MACF1 CCL3 FGFR3 UQCRFS1 NOTCH2 WWC1 VDAC1 | 2.84e-06 | 1276 | 182 | 25 | M39173 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | RRAS2 CLIC4 TFAP2A IFIT3 GFPT1 ESF1 MIPOL1 SEMA3A RIF1 BRCA2 CCZ1 ANLN UBA6 DIAPH3 ASCC3 HERC4 TOP2A MCOLN3 | 3.09e-06 | 721 | 182 | 18 | M10237 |
| Coexpression | GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_UP | 3.42e-06 | 172 | 182 | 9 | M2951 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | RRAS2 KLF6 AUH PIKFYVE SETD2 FAT1 C2CD3 PTPRK PARN GNAQ ASCC3 RAPGEF2 TOP2A WWC1 | 5.16e-06 | 466 | 182 | 14 | M13522 |
| Coexpression | IBRAHIM_NRF2_UP | AVEN HBS1L RRAS2 MAP2 KIAA0232 BACH1 TMED7 CLIC4 SLC6A15 GFPT1 ESF1 TRIM16 STK40 METAP2 VDAC1 | 5.18e-06 | 533 | 182 | 15 | M42510 |
| Coexpression | GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN | 1.12e-05 | 199 | 182 | 9 | M6837 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | RRAS2 AARS1 KLHL24 KLF6 PSG1 PSG7 PSG9 BACH1 PER1 CD55 GFPT1 TRIM16 TSC22D1 SETD2 FGFR1 CDC42 HERC4 EP300 | 1.83e-05 | 822 | 182 | 18 | M6782 |
| Coexpression | GSE7219_WT_VS_NIK_NFKB2_KO_DC_DN | 2.50e-05 | 169 | 182 | 8 | M379 | |
| Coexpression | MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY | 3.81e-05 | 10 | 182 | 3 | MM1261 | |
| Coexpression | MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY | 3.81e-05 | 10 | 182 | 3 | M1928 | |
| Coexpression | PASTURAL_RIZ1_TARGETS_UP | 3.81e-05 | 10 | 182 | 3 | M19828 | |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | 4.58e-05 | 184 | 182 | 8 | M9005 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | MYH3 KLF6 DUSP4 BACH1 PER1 CLIC4 SLC6A15 RRAS TFAP2B TSC22D1 ZNF23 IGF2R PTPRK MACF1 CCL3 GNAQ | 4.65e-05 | 721 | 182 | 16 | M1999 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | HBS1L RRAS2 PAG1 RAPGEF6 KLF6 IFIT3 IFNAR2 PTPRK RAB3IP SYNE2 MACF1 HERC3 RAPGEF2 | 4.86e-05 | 498 | 182 | 13 | M1741 |
| Coexpression | ODONNELL_TFRC_TARGETS_DN | 5.47e-05 | 139 | 182 | 7 | M6451 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | KLHL24 KLF6 MAP2 DDX60 DUSP4 CD55 PARP14 TFAP2A TRIM16 GUCY1A2 PTPRK HERC3 RAPGEF2 | 5.49e-05 | 504 | 182 | 13 | M2157 |
| Coexpression | GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_UP | 5.53e-05 | 189 | 182 | 8 | M9722 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | HBS1L RRAS2 PAG1 RAPGEF6 KLF6 IFIT3 IFNAR2 PTPRK RAB3IP SYNE2 MACF1 HERC3 RAPGEF2 | 5.83e-05 | 507 | 182 | 13 | MM1030 |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_DN | 5.96e-05 | 191 | 182 | 8 | M9977 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 6.95e-05 | 32 | 182 | 4 | MM2 | |
| Coexpression | DOUGLAS_BMI1_TARGETS_DN | NOL4 KLHL24 PAG1 RNF168 IFIT3 SEMA3A CCZ1 CLIC2 PAFAH2 RAPGEF2 | 7.35e-05 | 314 | 182 | 10 | M14279 |
| Coexpression | GSE14308_TH2_VS_TH1_UP | 7.94e-05 | 199 | 182 | 8 | M3359 | |
| Coexpression | GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN | 7.94e-05 | 199 | 182 | 8 | M6932 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_UP | 8.00e-05 | 102 | 182 | 6 | M10290 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_UP | 8.22e-05 | 200 | 182 | 8 | M9903 | |
| Coexpression | GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN | 8.22e-05 | 200 | 182 | 8 | M6095 | |
| Coexpression | GSE7852_LN_VS_FAT_TREG_DN | 8.22e-05 | 200 | 182 | 8 | M5742 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 9.95e-05 | 35 | 182 | 4 | MM757 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_UP | 1.00e-04 | 153 | 182 | 7 | M8249 | |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_UP | 1.00e-04 | 153 | 182 | 7 | M18058 | |
| Coexpression | NFE2L2.V2 | CYP4F8 HECW1 MAP2 KIAA0232 CIB4 MELTF L3HYPDH ALB XYLB CYP4F11 METAP2 HYDIN | 1.15e-04 | 469 | 182 | 12 | M2870 |
| Coexpression | GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_UP | 1.32e-04 | 160 | 182 | 7 | M8183 | |
| Coexpression | GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_UP | 1.49e-04 | 163 | 182 | 7 | M8663 | |
| Coexpression | YAGI_AML_WITH_INV_16_TRANSLOCATION | ADAM28 TRIM16 TSC22D1 MELTF ZNF23 BRCA2 SCN4A ALB FLRT1 IMMT TOP2A | 1.50e-04 | 411 | 182 | 11 | M1047 |
| Coexpression | MARZEC_IL2_SIGNALING_UP | 1.55e-04 | 115 | 182 | 6 | M13984 | |
| Coexpression | DESCARTES_FETAL_STOMACH_PARIETAL_AND_CHIEF_CELLS | 2.05e-04 | 42 | 182 | 4 | M40300 | |
| Coexpression | YU_MYC_TARGETS_UP | 2.05e-04 | 42 | 182 | 4 | MM1150 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | RAPGEF6 SETX ERCC5 ESRRG CD55 UPF3A ESF1 RIF1 ANLN SYNE2 DIAPH3 POLQ CPLANE1 METAP2 | 2.09e-04 | 656 | 182 | 14 | M18979 |
| Coexpression | YU_MYC_TARGETS_UP | 2.25e-04 | 43 | 182 | 4 | M1249 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 2.38e-04 | 176 | 182 | 7 | M39223 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 2.63e-04 | 300 | 182 | 9 | M8702 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.73e-04 | 180 | 182 | 7 | M8239 | |
| Coexpression | LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3 | 2.82e-04 | 181 | 182 | 7 | M39225 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 3.45e-04 | 48 | 182 | 4 | MM531 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 3.56e-04 | 87 | 182 | 5 | MM851 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP | AARS1 KLHL24 PAG1 ERN1 DUSP4 CD55 CLIC4 ASPHD2 IL18RAP IFIT3 GFPT1 IGF2R RAB3IP CCL3 RAPGEF2 | 3.68e-04 | 778 | 182 | 15 | M17915 |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_BCELL_DN | 4.03e-04 | 192 | 182 | 7 | M9987 | |
| Coexpression | BUSSLINGER_GASTRIC_PARIETAL_CELLS | 4.18e-04 | 254 | 182 | 8 | M40014 | |
| Coexpression | GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN | 4.29e-04 | 194 | 182 | 7 | M4687 | |
| Coexpression | GSE12366_GC_BCELL_VS_PLASMA_CELL_DN | 4.29e-04 | 194 | 182 | 7 | M3167 | |
| Coexpression | ONDER_CDH1_TARGETS_1_UP | 4.32e-04 | 139 | 182 | 6 | M18757 | |
| Coexpression | GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP | 4.42e-04 | 195 | 182 | 7 | M7926 | |
| Coexpression | GSE29618_BCELL_VS_PDC_UP | 4.56e-04 | 196 | 182 | 7 | M4940 | |
| Coexpression | GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_UP | 4.70e-04 | 197 | 182 | 7 | M6278 | |
| Coexpression | GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_DN | 4.85e-04 | 198 | 182 | 7 | M5084 | |
| Coexpression | GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_UP | 4.85e-04 | 198 | 182 | 7 | M6292 | |
| Coexpression | GSE12366_GC_VS_NAIVE_BCELL_UP | 4.85e-04 | 198 | 182 | 7 | M3168 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 4.85e-04 | 93 | 182 | 5 | M40279 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_DN | 4.99e-04 | 199 | 182 | 7 | M8265 | |
| Coexpression | GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN | 4.99e-04 | 199 | 182 | 7 | M7498 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_UP | 4.99e-04 | 199 | 182 | 7 | M3886 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 4.99e-04 | 199 | 182 | 7 | M5893 | |
| Coexpression | GSE3982_MAC_VS_TH2_UP | 4.99e-04 | 199 | 182 | 7 | M5513 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_ADDNL_EXON_LVL_UP | 5.09e-04 | 94 | 182 | 5 | M40880 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN | RRAS2 AUH ESRRG CLIC4 TSC22D1 FAT1 PRDX3 ALB SLC5A12 UQCRFS1 IMMT VDAC1 | 5.14e-04 | 553 | 182 | 12 | M1475 |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_DN | 5.14e-04 | 200 | 182 | 7 | M5975 | |
| Coexpression | GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP | 5.14e-04 | 200 | 182 | 7 | M8090 | |
| Coexpression | GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_UP | 5.14e-04 | 200 | 182 | 7 | M5838 | |
| Coexpression | GSE27786_LSK_VS_BCELL_UP | 5.14e-04 | 200 | 182 | 7 | M4743 | |
| Coexpression | GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_DN | 5.14e-04 | 200 | 182 | 7 | M6039 | |
| Coexpression | GSE2585_THYMIC_DC_VS_MTEC_DN | 5.14e-04 | 200 | 182 | 7 | M6283 | |
| Coexpression | GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_UP | 5.14e-04 | 200 | 182 | 7 | M6357 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_UP | 5.14e-04 | 200 | 182 | 7 | M4024 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_UP | 5.14e-04 | 200 | 182 | 7 | M6623 | |
| Coexpression | GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_DN | 5.14e-04 | 200 | 182 | 7 | M5592 | |
| Coexpression | GSE3982_DC_VS_MAC_UP | 5.14e-04 | 200 | 182 | 7 | M5458 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 5.30e-04 | 201 | 182 | 7 | MM1294 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | CAD ENPP3 TEX15 SRBD1 RNF17 SETDB2 RIF1 BRCA2 ANLN UBA6 ZNF420 HERC3 CPLANE1 TDRD12 | 4.85e-06 | 385 | 178 | 14 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | AVEN CAD SETX ENPP3 ALS2 TEX15 SRBD1 RNF17 ESF1 PIKFYVE SETDB2 RIF1 TARS3 BRCA2 ANLN UBA6 ZNF420 HERC3 DIAPH3 CPLANE1 TDRD12 | 5.55e-06 | 820 | 178 | 21 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_500 | RRAS2 RNF168 TFAP2A TFAP2B ZNF23 C2CD3 RAB3IP KCNJ16 SCNN1G FGF12 ASCC3 CPLANE1 MCOLN3 WWC1 | 8.87e-06 | 406 | 178 | 14 | gudmap_developingKidney_e15.5_ureter tip_500_flank cortic collct |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 5.26e-05 | 156 | 178 | 8 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#3_top-relative-expression-ranked_200 | 9.10e-05 | 11 | 178 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200_k3 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3 | KLF6 BACH1 LRRK2 PER1 CLIC4 WDFY4 IFIT3 GRAMD2A SETDB2 ARHGAP31 CCL3 FGFR1 | 1.01e-04 | 384 | 178 | 12 | GSM605820_500 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | SYNE1 CYP24A1 ESRRG LRRK2 CFAP54 SYNE2 FGFR1 RP1 DIAPH3 HYDIN WWC1 DNAH11 | 1.92e-11 | 186 | 183 | 12 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | SYNE1 ESRRG CFAP54 PTPRK SYNE2 MACF1 RP1 HYDIN TOP2A WWC1 DNAH11 | 5.99e-10 | 196 | 183 | 11 | 6d02d494196e3f857d53eea46d9419690d43beca |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | SYNE1 ESRRG CFAP54 PTPRK SYNE2 MACF1 RP1 HYDIN TOP2A WWC1 DNAH11 | 5.99e-10 | 196 | 183 | 11 | af4cdc61830685a888a1209826c23bcf54a43084 |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.77e-09 | 183 | 183 | 10 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NOL4 HECW1 SLC6A17 SPTA1 MELTF FAT1 CSMD1 USH2A HYDIN DNAH11 | 5.02e-09 | 184 | 183 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NOL4 HECW1 SLC6A17 SPTA1 MELTF FAT1 CSMD1 USH2A HYDIN DNAH11 | 5.02e-09 | 184 | 183 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NOL4 HECW1 SLC6A17 SPTA1 MELTF FAT1 CSMD1 USH2A HYDIN DNAH11 | 5.02e-09 | 184 | 183 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.77e-08 | 185 | 183 | 9 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.52e-08 | 187 | 183 | 9 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.91e-08 | 188 | 183 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.91e-08 | 188 | 183 | 9 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.22e-07 | 195 | 183 | 9 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.22e-07 | 195 | 183 | 9 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.22e-07 | 195 | 183 | 9 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-07 | 197 | 183 | 9 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-07 | 197 | 183 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.45e-07 | 199 | 183 | 9 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.51e-07 | 200 | 183 | 9 | 8827653738a931e4a4545e0c7d75be12bed40740 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.53e-07 | 154 | 183 | 8 | e94cd11488003347120eacd3ced0a8923ed09ccc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-07 | 155 | 183 | 8 | 969fc4c98a96bf2f436e8e63d4deb2183ef3b864 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-07 | 164 | 183 | 8 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.13e-07 | 169 | 183 | 8 | 54b13ab02b4c187f4754045ecfcf409749e7ccc0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.61e-07 | 171 | 183 | 8 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.61e-07 | 171 | 183 | 8 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.68e-07 | 175 | 183 | 8 | f7d191cde68de8f3457fa62b1df53b6d0dbe5001 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-07 | 176 | 183 | 8 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.99e-07 | 182 | 183 | 8 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 9.76e-07 | 184 | 183 | 8 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.76e-07 | 184 | 183 | 8 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-06 | 186 | 183 | 8 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-06 | 188 | 183 | 8 | 1a3f95b4fd7611c634666761ddf21f1e58e56af8 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.15e-06 | 188 | 183 | 8 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 189 | 183 | 8 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 189 | 183 | 8 | bd91bdfe35294e60d980259b70fe9e60dca2743f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 189 | 183 | 8 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-06 | 190 | 183 | 8 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-06 | 190 | 183 | 8 | be2b184a3559da41ba387ae0fdbeb9ae532868a5 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 1.34e-06 | 192 | 183 | 8 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 1.40e-06 | 193 | 183 | 8 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-06 | 193 | 183 | 8 | ffa1932da2979d7b63dbac32eb5788346a3f5b2a | |
| ToppCell | CF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 1.40e-06 | 193 | 183 | 8 | 7ebf20344a9a154fd2cffa281526867fcf0aded3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-06 | 194 | 183 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.51e-06 | 195 | 183 | 8 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.51e-06 | 195 | 183 | 8 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | mild_COVID-19_(asymptomatic)|World / disease group, cell group and cell class (v2) | 1.57e-06 | 196 | 183 | 8 | 8cb3dcb3e5732f4bb060c87ca339b8997a1a8cd4 | |
| ToppCell | Control-Myeloid-TRAM3|Control / Disease group,lineage and cell class （2021.01.30） | 1.63e-06 | 197 | 183 | 8 | 733ff40039d67e561c2ded7c9bd0b4353101741e | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.63e-06 | 197 | 183 | 8 | 0f1c4a328968b32874e6ebb0803e665adcbbc450 | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.63e-06 | 197 | 183 | 8 | 4416efdbd9c4ac3356a5dff2d535c2d7383376a9 | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.63e-06 | 197 | 183 | 8 | aafe0cd697b0b7f0756596148e0906443fdf8ef7 | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.63e-06 | 197 | 183 | 8 | e131634bc67e0bd31a938a8e8df8dc752e1d0f47 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.63e-06 | 197 | 183 | 8 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.75e-06 | 199 | 183 | 8 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-06 | 199 | 183 | 8 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.82e-06 | 200 | 183 | 8 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | COVID-19_Severe-multiplets|COVID-19_Severe / disease group, cell group and cell class | 3.23e-06 | 152 | 183 | 7 | 451745151322c2fcea22dbb3dba681e12634a510 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.52e-06 | 154 | 183 | 7 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.52e-06 | 154 | 183 | 7 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.12e-06 | 163 | 183 | 7 | a09449a502627aa369db600dba5bda93de7ce5c0 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.33e-06 | 164 | 183 | 7 | ed888b55d9c685096fd785878fcb264f4fee88d6 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.78e-06 | 166 | 183 | 7 | b1bebcbe17386cb102b11d551e62d46156ce0c68 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 6.01e-06 | 167 | 183 | 7 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.01e-06 | 167 | 183 | 7 | e44743b20a7435c579d8e999ddc4ca119d6753f2 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.25e-06 | 168 | 183 | 7 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.50e-06 | 169 | 183 | 7 | 0bc8ef341ce307b19018d4ac8de0a4d04254209d | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-06 | 169 | 183 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 6.75e-06 | 170 | 183 | 7 | d69c0ea4cb6b204f19d0a5d2164afb42184779ac | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.02e-06 | 171 | 183 | 7 | 41932c9e70829ee3d55ca5fdb74d290fc8229416 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.29e-06 | 172 | 183 | 7 | fb2df8fea6df5947165f13978f1d1006d15b60fd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.29e-06 | 172 | 183 | 7 | 86f52f486d67217fc1b8443ab362c975df2974a4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.29e-06 | 172 | 183 | 7 | e38ebb216e4ddcd008148fcbaf709b4f3c83706a | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 7.86e-06 | 174 | 183 | 7 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.47e-06 | 176 | 183 | 7 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 8.47e-06 | 176 | 183 | 7 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.79e-06 | 177 | 183 | 7 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.79e-06 | 177 | 183 | 7 | 73ba0f0b4b33f10e9f036d6d9befa48a1258e682 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.79e-06 | 177 | 183 | 7 | f925a15d2162d166a5b60edac3517c6b2d6cfbea | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.80e-06 | 180 | 183 | 7 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.80e-06 | 180 | 183 | 7 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.80e-06 | 180 | 183 | 7 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.80e-06 | 180 | 183 | 7 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.80e-06 | 180 | 183 | 7 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 181 | 183 | 7 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.02e-05 | 181 | 183 | 7 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 181 | 183 | 7 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 181 | 183 | 7 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | ASK454-Epithelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.05e-05 | 182 | 183 | 7 | ab15316cff989b61ff397a866d7ca8b49c13e981 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.09e-05 | 183 | 183 | 7 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.09e-05 | 183 | 183 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 184 | 183 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | IIF-Lymphocyte-T_NK-T_NK_proliferative|IIF / Disease, Lineage and Cell Type | 1.13e-05 | 184 | 183 | 7 | ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 186 | 183 | 7 | a417e1e21313a7e05951038cdef5ac672a9f727c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-05 | 187 | 183 | 7 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-05 | 187 | 183 | 7 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 188 | 183 | 7 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 1.30e-05 | 188 | 183 | 7 | 723348a1836a074e068320cb736ce6a953e0038f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 189 | 183 | 7 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 189 | 183 | 7 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 189 | 183 | 7 | 1ecf9911ff82e0ca0f0c101b735d3b1f3b339d57 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 189 | 183 | 7 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 1.35e-05 | 189 | 183 | 7 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| Computational | Neighborhood of EGFR | 3.07e-05 | 32 | 125 | 5 | GNF2_EGFR | |
| Computational | Neighborhood of MMP11 | 1.18e-04 | 42 | 125 | 5 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 1.84e-04 | 46 | 125 | 5 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 2.49e-04 | 49 | 125 | 5 | GNF2_KISS1 | |
| Computational | Neighborhood of CDKN1C | 2.49e-04 | 27 | 125 | 4 | GNF2_CDKN1C | |
| Drug | AC1L1IPV | 1.11e-06 | 43 | 181 | 6 | CID000004683 | |
| Drug | Asbestos, Crocidolite | MYH3 KLHL24 RAPGEF6 SETX SLC11A2 KLF6 PSG1 PSG3 PSG7 SYNE1 DUSP4 CYP24A1 ESRRG BACH1 PER1 CD55 ALS2 RRAS ESF1 SEMA3A TSC22D1 TAS1R1 CCL3 FGFR1 HERC4 CDH13 NOTCH2 | 1.90e-06 | 1241 | 181 | 27 | ctd:D017638 |
| Disease | Polydactyly | 6.35e-07 | 117 | 180 | 8 | C0152427 | |
| Disease | Malignant neoplasm of breast | CATSPERE SYNE1 CYP24A1 MTMR8 PER1 MCOLN1 TFAP2A MRPS22 EPG5 SEMA3A RIF1 SETD2 GUCY1A2 BRCA2 SYNE2 NECTIN2 MACF1 FGFR1 FASTKD3 EP300 TOP2A NOTCH2 | 7.30e-07 | 1074 | 180 | 22 | C0006142 |
| Disease | calcium measurement | ERCC5 GCM2 CYP24A1 ESRRG KIRREL3 MELTF SYNE2 SHOC1 AHSG MACF1 GNA11 FGFR1 ALB GNAQ ASCC3 POLQ | 1.71e-06 | 628 | 180 | 16 | EFO_0004838 |
| Disease | cD177 antigen measurement | 3.83e-06 | 18 | 180 | 4 | EFO_0021866 | |
| Disease | Primary Ciliary Dyskinesia | 9.96e-06 | 47 | 180 | 5 | C4551720 | |
| Disease | Diffuse Large B-Cell Lymphoma | 2.17e-05 | 55 | 180 | 5 | C0079744 | |
| Disease | Phakomatosis cesioflammea | 3.70e-05 | 2 | 180 | 2 | C3838883 | |
| Disease | Congenital hemangioma | 3.70e-05 | 2 | 180 | 2 | C0235753 | |
| Disease | Port-wine stain with oculocutaneous melanosis | 3.70e-05 | 2 | 180 | 2 | C1274879 | |
| Disease | peptide measurement | 5.71e-05 | 109 | 180 | 6 | EFO_0010520 | |
| Disease | Primary ciliary dyskinesia | 6.77e-05 | 36 | 180 | 4 | cv:C0008780 | |
| Disease | Cleft upper lip | 9.32e-05 | 39 | 180 | 4 | C0008924 | |
| Disease | Mammary Carcinoma, Human | SYNE1 CYP24A1 TFAP2A MRPS22 SETD2 GUCY1A2 BRCA2 NECTIN2 FGFR1 EP300 TOP2A NOTCH2 | 9.91e-05 | 525 | 180 | 12 | C4704874 |
| Disease | Mammary Neoplasms, Human | SYNE1 CYP24A1 TFAP2A MRPS22 SETD2 GUCY1A2 BRCA2 NECTIN2 FGFR1 EP300 TOP2A NOTCH2 | 9.91e-05 | 525 | 180 | 12 | C1257931 |
| Disease | Mammary Neoplasms | SYNE1 CYP24A1 TFAP2A MRPS22 SETD2 GUCY1A2 BRCA2 NECTIN2 FGFR1 EP300 TOP2A NOTCH2 | 1.03e-04 | 527 | 180 | 12 | C1458155 |
| Disease | mucolipidosis type IV (implicated_via_orthology) | 1.11e-04 | 3 | 180 | 2 | DOID:0080490 (implicated_via_orthology) | |
| Disease | Costello syndrome (implicated_via_orthology) | 1.11e-04 | 3 | 180 | 2 | DOID:0050469 (implicated_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.14e-04 | 41 | 180 | 4 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.14e-04 | 41 | 180 | 4 | C0858252 | |
| Disease | Breast Carcinoma | SYNE1 CYP24A1 TFAP2A MRPS22 SETD2 GUCY1A2 BRCA2 NECTIN2 FGFR1 EP300 TOP2A NOTCH2 | 1.24e-04 | 538 | 180 | 12 | C0678222 |
| Disease | HMG CoA reductase inhibitor use measurement | 1.68e-04 | 189 | 180 | 7 | EFO_0009932 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.18e-04 | 139 | 180 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | TWIST1-related craniosynostosis | 2.20e-04 | 4 | 180 | 2 | cv:C4551902 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 2.20e-04 | 4 | 180 | 2 | cv:CN293514 | |
| Disease | Clinodactyly | 2.20e-04 | 4 | 180 | 2 | C4551485 | |
| Disease | Clinodactyly of fingers | 2.20e-04 | 4 | 180 | 2 | C0265610 | |
| Disease | glycoproteinosis (implicated_via_orthology) | 2.20e-04 | 4 | 180 | 2 | DOID:3343 (implicated_via_orthology) | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 3.66e-04 | 5 | 180 | 2 | C1450051 | |
| Disease | Malignant melanoma of iris | 3.66e-04 | 5 | 180 | 2 | C0346373 | |
| Disease | Malignant melanoma of choroid | 3.66e-04 | 5 | 180 | 2 | C0346388 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 3.66e-04 | 5 | 180 | 2 | C0410190 | |
| Disease | bone disease (implicated_via_orthology) | 3.66e-04 | 5 | 180 | 2 | DOID:0080001 (implicated_via_orthology) | |
| Disease | cerebellar ataxia (is_implicated_in) | 3.66e-04 | 5 | 180 | 2 | DOID:0050753 (is_implicated_in) | |
| Disease | Neoplasm of the genitourinary tract | 4.11e-04 | 24 | 180 | 3 | cv:C0042065 | |
| Disease | response to angiotensin-converting enzyme inhibitor, response to angiotensin receptor blocker, angioedema | 5.23e-04 | 26 | 180 | 3 | EFO_0005325, EFO_0005532, EFO_0010735 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 5.33e-04 | 61 | 180 | 4 | C1961102 | |
| Disease | Emery-Dreifuss muscular dystrophy | 5.46e-04 | 6 | 180 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 5.46e-04 | 6 | 180 | 2 | C0410189 | |
| Disease | Ciliopathies | 5.83e-04 | 110 | 180 | 5 | C4277690 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 6.54e-04 | 28 | 180 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | oral squamous cell carcinoma (is_implicated_in) | 6.54e-04 | 28 | 180 | 3 | DOID:0050866 (is_implicated_in) | |
| Disease | pneumonia, COVID-19 | 6.59e-04 | 113 | 180 | 5 | EFO_0003106, MONDO_0100096 | |
| Disease | eosinophil percentage of leukocytes | SH3TC2 HBS1L AUH IL18RAP ME2 GGT5 IFNAR2 MIPOL1 SETD2 ZNF420 ASB2 NOTCH2 VDAC1 | 7.02e-04 | 746 | 180 | 13 | EFO_0007991 |
| Disease | breast carcinoma (is_marker_for) | 7.19e-04 | 66 | 180 | 4 | DOID:3459 (is_marker_for) | |
| Disease | wellbeing measurement, smoking behaviour measurement | 7.62e-04 | 7 | 180 | 2 | EFO_0005671, EFO_0007869 | |
| Disease | Craniosynostosis syndrome | 7.62e-04 | 7 | 180 | 2 | cv:C0010278 | |
| Disease | substance-related disorder (implicated_via_orthology) | 7.62e-04 | 7 | 180 | 2 | DOID:303 (implicated_via_orthology) | |
| Disease | infertility (implicated_via_orthology) | 7.62e-04 | 7 | 180 | 2 | DOID:5223 (implicated_via_orthology) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 7.62e-04 | 7 | 180 | 2 | C0751337 | |
| Disease | prostate cancer (is_implicated_in) | 7.71e-04 | 117 | 180 | 5 | DOID:10283 (is_implicated_in) | |
| Disease | eosinophil count | SH3TC2 HBS1L RAPGEF6 PSG1 AUH KIAA0232 SEC31A IL18RAP ME2 TFAP2B GGT5 IFNAR2 MIPOL1 SETD2 MELTF NECTIN2 ZNF420 ASB2 NOTCH2 VDAC1 | 7.94e-04 | 1488 | 180 | 20 | EFO_0004842 |
| Disease | melanoma | 8.58e-04 | 248 | 180 | 7 | C0025202 | |
| Disease | colorectal cancer (is_implicated_in) | 8.97e-04 | 121 | 180 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | Hereditary spherocytosis | 1.01e-03 | 8 | 180 | 2 | C0037889 | |
| Disease | hypokalemic periodic paralysis (implicated_via_orthology) | 1.01e-03 | 8 | 180 | 2 | DOID:14452 (implicated_via_orthology) | |
| Disease | C-C motif chemokine 3-like 1 measurement | 1.01e-03 | 8 | 180 | 2 | EFO_0008052 | |
| Disease | alcoholic hepatitis (is_marker_for) | 1.01e-03 | 8 | 180 | 2 | DOID:12351 (is_marker_for) | |
| Disease | Uveal melanoma | 1.01e-03 | 8 | 180 | 2 | C0220633 | |
| Disease | Kartagener Syndrome | 1.27e-03 | 35 | 180 | 3 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 1.27e-03 | 35 | 180 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 1.27e-03 | 35 | 180 | 3 | C4317124 | |
| Disease | RASopathy (implicated_via_orthology) | 1.30e-03 | 9 | 180 | 2 | DOID:0080690 (implicated_via_orthology) | |
| Disease | Malignant tumor of prostate | 1.30e-03 | 9 | 180 | 2 | cv:C0376358 | |
| Disease | liver cancer (is_marker_for) | 1.30e-03 | 9 | 180 | 2 | DOID:3571 (is_marker_for) | |
| Disease | urinary bladder cancer (implicated_via_orthology) | 1.30e-03 | 9 | 180 | 2 | DOID:11054 (implicated_via_orthology) | |
| Disease | multiple myeloma (is_marker_for) | 1.37e-03 | 36 | 180 | 3 | DOID:9538 (is_marker_for) | |
| Disease | Prostatic Neoplasms | KLF6 CLIC4 RRAS ADAM28 SETD2 IGF2R BRCA2 PTPRK NECTIN2 TOP2A CDH13 | 1.48e-03 | 616 | 180 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | KLF6 CLIC4 RRAS ADAM28 SETD2 IGF2R BRCA2 PTPRK NECTIN2 TOP2A CDH13 | 1.48e-03 | 616 | 180 | 11 | C0376358 |
| Disease | macrophage colony stimulating factor measurement | 1.49e-03 | 37 | 180 | 3 | EFO_0008217 | |
| Disease | Congenital myasthenic syndrome | 1.61e-03 | 10 | 180 | 2 | cv:C0751882 | |
| Disease | Hodgkins lymphoma | 1.62e-03 | 82 | 180 | 4 | EFO_0000183 | |
| Disease | Giant Cell Glioblastoma | 1.77e-03 | 84 | 180 | 4 | C0334588 | |
| Disease | Malignant neoplasm of urinary bladder | 1.77e-03 | 141 | 180 | 5 | C0005684 | |
| Disease | Parkinson Disease | 1.85e-03 | 85 | 180 | 4 | C0030567 | |
| Disease | NG-monomethyl-arginine measurement | 1.96e-03 | 11 | 180 | 2 | EFO_0010510 | |
| Disease | interleukin 1 receptor-like 1 measurement | 1.96e-03 | 11 | 180 | 2 | EFO_0008168 | |
| Disease | sleep disorder (implicated_via_orthology) | 1.96e-03 | 11 | 180 | 2 | DOID:535 (implicated_via_orthology) | |
| Disease | Cutaneous Melanoma | 2.01e-03 | 41 | 180 | 3 | C0151779 | |
| Disease | Back pain | 2.01e-03 | 87 | 180 | 4 | HP_0003418 | |
| Disease | Glioma | 2.01e-03 | 87 | 180 | 4 | C0017638 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.14e-03 | 291 | 180 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 2.35e-03 | 12 | 180 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | apolipoprotein B measurement | HBS1L PSG1 DUSP4 IGF2R BRCA2 SYNE2 NECTIN2 RP1 FLRT1 HYDIN DNAH11 | 2.62e-03 | 663 | 180 | 11 | EFO_0004615 |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 2.62e-03 | 45 | 180 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | Craniofacial Abnormalities | 2.75e-03 | 156 | 180 | 5 | C0376634 | |
| Disease | Benign tumor of pancreas | 2.76e-03 | 13 | 180 | 2 | C0347284 | |
| Disease | skin and soft tissue Staphylococcus aureus infection | 2.76e-03 | 13 | 180 | 2 | EFO_1001489 | |
| Disease | nodular sclerosis Hodgkin lymphoma | 3.21e-03 | 14 | 180 | 2 | EFO_0004708 | |
| Disease | response to methotrexate, aspartate aminotransferase measurement | 3.21e-03 | 14 | 180 | 2 | EFO_0004736, GO_0031427 | |
| Disease | nephroblastoma (is_implicated_in) | 3.21e-03 | 14 | 180 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 3.21e-03 | 14 | 180 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | Hermansky-Pudlak syndrome (implicated_via_orthology) | 3.21e-03 | 14 | 180 | 2 | DOID:3753 (implicated_via_orthology) | |
| Disease | alpha fetoprotein measurement | 3.33e-03 | 100 | 180 | 4 | EFO_0010583 | |
| Disease | Adenoid Cystic Carcinoma | 3.33e-03 | 100 | 180 | 4 | C0010606 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 3.35e-03 | 49 | 180 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | PR interval | 3.50e-03 | 495 | 180 | 9 | EFO_0004462 | |
| Disease | response to fenofibrate | 3.54e-03 | 50 | 180 | 3 | GO_1901557 | |
| Disease | malaria | 3.58e-03 | 102 | 180 | 4 | EFO_0001068 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.58e-03 | 239 | 180 | 6 | EFO_0008317, EFO_0020945 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 3.69e-03 | 15 | 180 | 2 | C0496930 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IAAKYQIDPDACFSA | 221 | P21796 | |
| TCFDKSQVPTIDQDY | 936 | Q13075 | |
| YCSKLSEVFEQEIDP | 1141 | Q09472 | |
| TEACITAYFKESPLN | 2326 | Q9HCE0 | |
| YSAADCPLSFLISEK | 641 | O14867 | |
| YFETNSECSKPGVIF | 71 | P55773 | |
| KFLQLYSSSCIDEFP | 2856 | Q96N23 | |
| TNTCPSDKEVEIAYS | 231 | Q9Y696 | |
| CFSALEVDETYVPKE | 511 | P02768 | |
| DSESPCETVSQKDVY | 576 | Q9BXX2 | |
| EAQSIAFTTKDKCPY | 571 | Q5SY80 | |
| QLTYTSFDLVKCEDP | 1206 | Q96PZ7 | |
| TFLTCKTFDPEDTSQ | 581 | Q9UKQ2 | |
| TCFEVASPEYQKLQD | 856 | Q96Q42 | |
| ADKEPSVVQFCEFVS | 531 | Q96Q27 | |
| YVCETEFPAKAVAEF | 306 | P05549 | |
| KLFKQSTYDPSDCTN | 516 | Q96DT5 | |
| ADKYDPFTTTNTECL | 481 | P56282 | |
| TKSSCVVDVTYFPFD | 151 | Q9UGM1 | |
| YPTVAEVCDDAKNLS | 586 | P55290 | |
| SQFKSEYSNLCEPEQ | 771 | Q9NSV4 | |
| FCAENPEETVSKRDY | 146 | P36575 | |
| ICETEFPAKAVSEYL | 326 | Q92481 | |
| YQEDIFPCLTFSKSE | 341 | Q96QF0 | |
| EEHTDTCLPKQSVYD | 101 | P48382 | |
| LNPDSDKIIYSHFTC | 316 | P50148 | |
| VEDDYCISPSTAAQF | 26 | Q9Y450 | |
| SPDVKFVCQSSSIDF | 101 | O95453 | |
| PSLDCFFKYNATTDQ | 471 | Q8NAB2 | |
| PDCYTFSVLITFDNK | 251 | Q9GZU1 | |
| ANDNSPVCEKTLYSD | 3016 | Q14517 | |
| AVCKESPNFESYTCL | 846 | Q04721 | |
| CATDPNSYKSLVDSF | 46 | Q9BQT8 | |
| EVKPQTNASCEYSAS | 146 | O95256 | |
| IDCAFTVTFNPKYDT | 261 | P50579 | |
| LQASGDKEPVTFCTY | 621 | Q68CZ1 | |
| PKADEQTTCEVLDYF | 961 | Q8N201 | |
| PDCYDFTLTITFDNK | 236 | Q8TDD5 | |
| YTKPLTFADCISDEL | 41 | Q8IX03 | |
| PDDESVYCTTEKYNV | 71 | Q8TD10 | |
| DSKEVSPIFTQFLDC | 391 | Q96EF0 | |
| AIEEACYAQTIPTKD | 306 | Q13825 | |
| DTVTLCSYPFIFDAQ | 646 | Q15034 | |
| DASSYFVEPETKICF | 146 | Q76N89 | |
| DFVCSTVQKPDAANY | 816 | Q9NQW6 | |
| CEQTSDYQSPVDSKD | 651 | Q9NR82 | |
| PEDTVITYKCEESFV | 56 | P08174 | |
| PQDCTYADQKAVDTE | 1221 | Q8IY21 | |
| TKTFQAEPCAFVVDT | 576 | Q5CZC0 | |
| AVVDCDSPETASKIY | 436 | Q9H501 | |
| VPEEAERKEASSCSY | 611 | O15534 | |
| LFPASECEECYTNAK | 1296 | Q92628 | |
| VTICTYPFVFDAQAK | 656 | Q5GLZ8 | |
| ENFLEACPKVESFSA | 1146 | Q5S007 | |
| CPEDINTFKLLSYAS | 681 | Q16891 | |
| YSLVVFNTVDCAPES | 66 | Q71SY5 | |
| FNEKISIPEEEYSCF | 51 | P49281 | |
| CSSYEDKTIPIDLVF | 131 | A8MYU2 | |
| CFSVVSPSSFENVKE | 81 | P60953 | |
| LSFVDACYSSAIAPK | 66 | Q8NH18 | |
| VTLSNEPFKCDSDFY | 131 | Q8TAC1 | |
| NECKEKSYQEVSFDP | 3171 | Q9UPN3 | |
| SPDYTDESCTFKISL | 31 | P48551 | |
| ALSCSDTYIPETAVF | 186 | Q8NGG1 | |
| DPEYNTVASKFNQTC | 1626 | Q460N5 | |
| EPSSIIAFALSCKEY | 1666 | Q9Y2I7 | |
| EFETLYKAFSNCSLP | 201 | Q6ICH7 | |
| FTPEENKDYAHTLTC | 166 | Q4G0P3 | |
| AKLPEFTKSEYAVCA | 346 | Q6TFL4 | |
| NTCSDKVQSYDPETN | 466 | Q6TFL4 | |
| VCFAENPDTIKDSSF | 241 | Q4AC94 | |
| FKDIEEQYPTSLACV | 1031 | P51587 | |
| ENVEKETAKSPATCY | 1641 | P51587 | |
| EKYSQQPSADFLCDI | 291 | Q07973 | |
| GSCFVVAPESYESEK | 1616 | Q9H799 | |
| DCKENPTYTVDIFSA | 746 | O75460 | |
| EASCPKQNSAFYVDS | 166 | Q9NQS1 | |
| VPPSESQKCSFYLAD | 671 | O14638 | |
| PEEQLSSKDLVSCAY | 591 | P11362 | |
| SVVYAKCDSSPDSAE | 126 | P02765 | |
| GCPFVSKQSIYTEDD | 441 | Q9NQL9 | |
| YDDCSSTIVEDPQTK | 101 | P62508 | |
| SDKECSVVIYDFIQS | 1956 | O75417 | |
| ESNCQEKPSEYIAAI | 211 | Q9HBI6 | |
| LNPDSDKIIYSHFTC | 316 | P29992 | |
| CRFPKIFVNTDDTYE | 296 | P86791 | |
| DSNCQEKPSEYITAI | 211 | P98187 | |
| AEFLETECYQTPFNK | 336 | O14879 | |
| TECYQTPFNKEVPDA | 341 | O14879 | |
| CRFPKIFVNTDDTYE | 296 | P86790 | |
| SKGCVEYEPNFSQEV | 526 | P36269 | |
| FIADYFETSSQCSKP | 46 | P10147 | |
| NPTAQAECTAEEAYT | 421 | P23368 | |
| TDVFCTENYLKVNFP | 31 | Q8WXU2 | |
| TYFSEPVSCEVTNAL | 306 | Q8IZU9 | |
| PTLEDLEQFSEKFYC | 421 | P38567 | |
| VCSKNDYVPVFESSS | 106 | Q86UP6 | |
| LVECTSAKAFYIPET | 181 | Q9NQM4 | |
| NAYVADETPVCAKAE | 486 | Q9NZU1 | |
| DYSFDTCKPPEEQLT | 576 | P22607 | |
| FSTAEESESCFAQPK | 26 | Q6P6B1 | |
| CSPTAKNAVYEEDEL | 281 | Q8IUY3 | |
| SSEYPEFCSKTKALA | 151 | Q13115 | |
| ESFKLSEPYSQCTED | 361 | P51170 | |
| THTCPEDKEIENTYA | 226 | O15247 | |
| DVLNFTCEPKSENYT | 256 | P11464 | |
| KCSDYESIEVPDSYT | 101 | O14830 | |
| ETAIPVCEFKAAYFD | 1146 | Q15262 | |
| AATTYFCKQAPEENQ | 141 | Q99487 | |
| DVLAFTCEPKSENYT | 256 | Q16557 | |
| PSLDFCYDSKQNSEK | 1536 | P56715 | |
| EDCFEIVSPKVNATF | 361 | P33402 | |
| YSSDVFTPECKFKES | 136 | P61328 | |
| NTYFEFETALACVPS | 1066 | P11717 | |
| CFAQFEPDSTEYIKV | 231 | P82650 | |
| GPTCEKYALQVSSEF | 706 | A2RTX5 | |
| VPFAKYDFSVQACTS | 1211 | O75445 | |
| TFVEPECEQSSATTY | 191 | Q9H2J7 | |
| ADYRVQPCKFEDSQV | 386 | Q96M34 | |
| AEVEPTDSEPYSCSK | 1401 | Q8TEU7 | |
| SQEAKVTEECSQYEF | 361 | Q8N2I9 | |
| NSSVCSTADYKPPEE | 961 | P35499 | |
| PKDCDVLTAVSEFFN | 501 | P08582 | |
| SELAKPIVYDSCNSE | 7906 | Q8NF91 | |
| CPNSSEVLYTSAKEE | 6161 | Q8WXH0 | |
| STTCLFPVEEKAVEY | 261 | Q06210 | |
| FCLYNPKITSELSEA | 81 | Q5UIP0 | |
| DFYNSTCQDIEIKPL | 41 | Q587J7 | |
| LETYCVEEEKTSANP | 181 | Q9H1J1 | |
| DVLNFTCEPKSENYT | 256 | Q9UQ74 | |
| DVLAFTCEPKSENYT | 256 | Q00887 | |
| AVAETFVCQTEKFSP | 391 | Q14CZ7 | |
| PKSDVYKATCDLATF | 236 | O75603 | |
| QNELCPYESKFDSSL | 546 | P28715 | |
| TDYDPTIEDSYTKQC | 41 | P62070 | |
| ACKISPASYNKEESE | 611 | Q7Z333 | |
| DYNEVFTPVSCLEKC | 61 | Q5VXU9 | |
| QSETPTYSECFASKG | 851 | Q9ULL8 | |
| FQTPEDQELTYTCTA | 181 | Q9UIB8 | |
| DFSTEIPADYQRICK | 136 | O15127 | |
| PTVSSECIASSEYKE | 26 | Q8TF17 | |
| PFDAKTYCFVVDSKE | 31 | P11055 | |
| FVCPTEIVAFSDKAN | 106 | P30048 | |
| CTEFYEKENAVPATE | 426 | Q15714 | |
| YGVENSSTFLECSPK | 586 | Q14563 | |
| DVSTFTCEPKSENYT | 256 | Q13046 | |
| SPSSCNDLYATVKDF | 351 | Q9NWQ8 | |
| AFTCEEYVKSLTANP | 191 | Q9Y2L1 | |
| DKQCKPEATQATYST | 521 | O94818 | |
| NCKTFEELEHVSAPY | 301 | Q8N5C6 | |
| AYTKEPTTNICVFAD | 251 | Q96EM0 | |
| CPDYDTDTKTVLDQA | 1906 | Q8N3C0 | |
| VFSEQACPSLKIEYA | 91 | A0PJX0 | |
| EFRDSTKCYPQENEI | 306 | Q9BXT8 | |
| FAVTATPDQYSLCEV | 641 | Q9Y4G8 | |
| CPTTETIYNDEFYTK | 546 | A0AVT1 | |
| SFPEDCTFLTTENKE | 106 | Q96T68 | |
| VCYSHTDIKVPDFSE | 76 | P47985 | |
| DLPENYNEAKCVTFS | 751 | Q7RTX1 | |
| EAAKAVYTQDCPLAA | 661 | P49588 | |
| PATAEDQDSQYVCFT | 51 | Q96BH1 | |
| SVEVYAPFCSAKQLD | 331 | Q9NPI9 | |
| EITFELPDNAKQCFY | 36 | Q9Y3B3 | |
| FDAPVYVIDTANSAC | 456 | O75191 | |
| SEKCEEPQANPSTFY | 361 | P16471 | |
| PECKTEDFVSCIENY | 2216 | Q6ZS81 | |
| ITAVQPEDSATYFCA | 96 | A0A075B6U4 | |
| LYEKFTEAVSHCPEE | 111 | Q2M1Z3 | |
| PTACDESYKDATNIQ | 1521 | P02549 | |
| KEAVTLDCTYDTSDP | 36 | A0A0A6YYC5 | |
| QESSFEAVKDPCFSA | 391 | Q8IYW5 | |
| TAAFEPSVDYCVVKI | 726 | P27708 | |
| AAKDLPSNTFVLEYC | 1566 | Q9BYW2 | |
| QAEISCESPFLAKDF | 781 | P11137 | |
| GEDYTCITFQPDLSK | 211 | P11388 | |
| TYVCDILKPFEEATQ | 686 | P86452 | |
| CASKDLSPEKNTYET | 51 | Q8TAQ5 | |
| CKFKNTEDITFPSVY | 286 | O95361 | |
| VVEAECEKSSATTYF | 191 | Q9H1V8 | |
| KDETSPVEECFFSQS | 111 | P17027 | |
| IYQFKETCSSESPDF | 621 | Q9BXT5 | |
| PSDATYTALFNVCAE | 206 | O75127 | |
| SDYDPTIEDSYTKIC | 56 | P10301 | |
| VLTYAKPDEFSALCD | 656 | O94979 | |
| LATVTFEDFVKSCFP | 356 | Q1EHB4 | |
| EPCYVSASEIKFDSQ | 46 | Q99612 | |
| KTPYFDAGASCTEQE | 436 | Q92692 |